Carboxyamidotriazole orotate is primarily investigated for its potential therapeutic applications in the field of oncology. It has been studied as an anti-cancer agent due to its ability to inhibit calcium influx, which plays a critical role in tumor cell proliferation and angiogenesis. By blocking calcium channels, it may help reduce the growth and spread of cancer cells, particularly in solid tumors. Additionally, it has shown promise in preclinical studies for its anti-metastatic properties, potentially limiting the migration of cancer cells to other parts of the body. Beyond oncology, it has been explored for its anti-inflammatory effects, which could be beneficial in treating conditions involving chronic inflammation. Its unique mechanism of action makes it a compound of interest for further research in targeted cancer therapies and related fields.